$BMRN

BioMarin Pharmaceutical Inc. Demonstrates Strong Q2 Performance Amid Biotech Volatility

$BMRN BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leader in genetic therapies, reported a robust Q2 2024, with revenue surging 20%…